Lilly pays US$1.2 billion for Ventyx and its oral anti-inflammatories

Nature Reviews Drug Discovery 2026

View at publisher

Authors: Asher Mullard

DOI: 10.1038/d41573-026-00009-5

Cited by: 0

Fields of Study & Subjects

Pharmaceutical Economics and Policy Corporate Finance and Governance Intellectual Property and Patents